References
- Guo L, Dial S, Shi L, Branham W, Liu J, Fang J-L, Green B, Deng H, Kaput J, and Ning B. (2011) Similarities and differences in the expression of drug metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metabolism and Disposition 39(3): 528-538.
- Zuo R, Li F, Parikh S, Cao L, Cooper, KL, Hong Y, Liu J, Faris R, Li D, and Wang H. (2017) Evaluation of a novel renewable hepatic cell model for prediction of clinical CYP3A4 induction using a correlation-based relative induction score approach. Drug Metabolism and Disposition 45: 198-207
- Donato MT, Jover R and Gómez-Lechón MJ. (2013) Hepatic cell lines for drug hepatotoxicity testing: Limitations and strategies to upgrade their metabolic competence by gene engineering. Current Drug Metabolism 14: 946-968.
- Thomas E and Liang TJ. (2016) Experimental models of hepatitis B and C – new insights and progress. Nature Reviews Gastroenterology and Hepatology 13(6): 362-374.
- Tolosa L, Gómez-Lechón MJ, López S, Guzmán C, Castell J, Donato MT and Jover R. (2016) Human Upcyte hepatocytes: Characterization of the Hepatic Phenotype and evaluation for acute and long-term hepatotoxicity routine testing. Toxicological Sciences 152(1) 214-229.
- Verrier ER, Colpitts CC, Schuster C, Zeisel MB and Baumert TF. (2016) Cell culture models for the investigation of hepatitis B and D virus infection. Viruses 8: 261.
- Gómez-Lechón MJ and Tolosa L. (2016) Human hepatocytes derived from pluripotent stem cells: A promising cell model for drug hepatotoxicity screening. Archives of Toxicology 90: 2049-2061.
- Lauschke VM, Hendriks DFG, Bell CC, Andersson TB, and Ingelman-Sundberg M. (2016) Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates. Chemical Research in Toxicology 29(12): 1936-1955. DOI: 10.1021/acs.chemrestox.6b00150.
- Yamazaki H, Suemizu H, Mitsui M, Shimizu M, and Guengerich FP. (2016) Combining Chimeric Mice with Humanized Liver, Mass Spectrometry, and Physiologically-Based Pharmacokinetic Modeling in Toxicology. Chemical Research in Toxicology 29(12): 1903-1911.
- Raphemot R, Posfai D and Derbyshire ER. (2016) Current therapies and future possibilities for drug development against liver-stage malaria. Journal of Clinical Investigations 126(6): 2013-2020. DOI: 10.1172/JCI82981.
- Davidson MD, Kulka DA, and Khetani SR. (2017) Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development. Integrative Biology 9: 662-677.
- U.S. Food and Drug Administration. Drug development and drug interactions website. https://www.fda.gov/drugs/developmentapprovalprocess/developmentresources/druginteractionslabeling/ucm080499.htm. Accessed November 29, 2017.